Research: All Articles
Cates A. Medication, ID Theft, and Health Care: A Haven for the Criminal Element. J Biolaw Bus. 2006;9(4):61-64.
Fraud in medication claims results in significant false claims. Yet the systems that purportedly are designed to detect such claims are limited in effectiveness. In combination with the porousness of the US drug supply, the criminal element has entered into the pharmaceutical distribution world with little risk and high returns. To address this combination, spot…
[...]Liang BA.* Fade to Black: Importation and Counterfeit Drugs. Am J Law Med. 2006 Feb 1;32(2-3):279-323
Abstract. Importation of medicines from Canada and other countries has been proposed to provide relief from high drug prices in the US and greater access for underserved patients. Yet importation necessarily raises the issue of counterfeit drugs. The latter are a worldwide problem that have affected even the US closed regulatory and supply system. Counterfeit…
[...]Giacolone RP. Drug Wholesaling and Importation: Challenges and Opportunities. California Western Intl Law J. 2005;36:65-76.
Much interest and controversy abounds regarding the benefits and perils associated with the importation of pharmaceuticals. The Internet has provided an uncertain vehicle for such importation especially as it pertains to two key areas: product authentication and product integrity. As a result, questions exist as to whether other U.S. entities may provide a more legitimate…
[...]Gilbert T, Halwani S. Confusion and Contradiction: Untangling Drug Importation and Counterfeit Drugs. California Western Intl Law J. 2005;36:41-54.
Drug importation from Canada is an issue attracting tremendous attention in the United States. The issue of importation is intertwined with the potential for counterfeit drugs, and several considerations regarding this issue deserve attention. First, drugs used in the United States and Canada are manufactured around the world. Second, many of the counterfeiting issues focus…
[...]Rodriguez RF. Drug Importation and the Hispanic Physician. California Western Intl Law J. 2005;36:117-124.
Personal and commercial importation is a topic that has beenframed in the context of consumers versus industry. Yet it is the physician and other providers who must be part of the system of care with a stake in ensuring their patients obtain medicines that promote health. Both personal and commercial importation has significant risks. Investigations,…
[...]Bro WP. Importation of Prescription Drugs and Risks to Patient Safety. California Western Intl Law J. 2005;36:105-116.
Access to affordable prescription drug products is a serious challenge faced by millions of Americans. More than 40% of Americans take one or more prescription drugs; and a small, but increasing, number rely on drug importation to lower costs. Although some imported drugs are legal, a far greater number are unregulated within the U.S. drug…
[...]Langston EL. The Quality Quandary. California Western Intl Law J. 2005;36:19-32.
America’s physicians write over three billion prescriptions a year for patients1—and they need to know that when patients fill those prescriptions, the drugs they take are safe. Physicians want their patients to be able to get those drugs at the lowest price possible. Patient safety and drug quality are the overriding issues, as physicians work…
[...]Liang BA.* Measuring the Impact of Counterfeit Drugs: Applying the Patient Safety Reporting System Approach. Proceedings of the OECD/WIPO meeting on measurement of counterfeiting and piracy, 17-18 October 2005.
Counterfeit Drugs At least $32/€27 billion annually. $88/€73 million a day. Estimates: grow to $75/€62 billion annually in 5 years. Up to 60% of drugs in developing countries are counterfeit Up to 90% artenusate in Southeast Asia fake. Up to 20% of drugs sold in some developed countries counterfeit. Up to 15% of all drugs…
[...]Liang BA.* Over The Virtual and Geographic Borders: Understanding Importation and Counterfeit Drugs. Cal W Int Law J. 2005 Jun 3;36(1):7-18
Abstract. U.S. citizens depend extensively on medicines for health and quality of life. Yet a major problem attends the drug supply: counterfeit medicines. Although currently the United States has a relatively safe, closed system, it has not been immune to counterfeits, and harm associated with counterfeits has occurred here. Further, because terrorist activities have been…
[...]Liang BA.* International Drug Importation: Issues in Public Policy, Patient Safety, and the Public Health. Cal W Int Law J. 2005 Jun 3;36(1):1-6
Abstract. This issue of the California Western International Law Journal memorializes the proceedings of the First Annual San Diego Health Policy Conference, International Drug Importation: Issues in Public Policy, Patient Safety, and the Public Health. Leaders from medicine, law, public policy, academia, and patient care groups gathered together on June 3-4, 2005 to discuss the…
[...]